Design, synthesis, and evaluation of a novel macrocyclic anti-EV71 agent.
Li, P., Wu, S., Xiao, T., Li, Y., Su, Z., Wei, W., Hao, F., Hu, G., Lin, F., Chen, X., Gu, Z., Lin, T., He, H., Li, J., Chen, S.(2020) Bioorg Med Chem 28: 115551-115551
- PubMed: 32503695
- DOI: https://doi.org/10.1016/j.bmc.2020.115551
- Primary Citation of Related Structures:
6LKA - PubMed Abstract:
We describe here the design, synthesis, and evaluation of a macrocyclic peptidomimetic as a potent agent targeting enterovirus A71 (EV71). The compound has a 15-membered macrocyclic ring in a defined conformation. Yamaguchi esterification reaction was used to close the 15-membered macrocycle instead of the typical Ru-catalyzed ring-closing olefin metathesis reaction. The crystallographic characterization of the complex between this compound and its target, 3C protease from EV71, validated the design and paved the way for the generation of a new series of anti-EV71 agents.
Organizational Affiliation:
State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, State-province Joint Engineering Laboratory of Targeted Drugs from Natural Products, School of Life Sciences, Xiamen University, Xiamen, Fujian, China; Cancer Research Center of Xiamen University, Xiamen, Fujian, China; State Key Laboratory of Drug Lead Compound Research, WuXi AppTec (Shanghai) Co., Ltd., Shanghai, China.